Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii

Pan-drug-resistant (PDR) Acinetobacter baumannii is an important nosocomial pathogen that poses therapeutic challenges. Tigecycline alone or in combination with agents such as colestimethate, imipenem, and/or amikacin is being used clinically to treat PDR A. baumannii infections. The purpose of this...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Sopirala, Madhuri M., Mangino, Julie E., Gebreyes, Wondwossen A., Biller, Beth, Bannerman, Tammy, Balada-Llasat, Joan-Miquel, Pancholi, Preeti
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2010
Aiheet:
Susceptibility
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976112/
https://ncbi.nlm.nih.gov/pubmed/20713678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00497-10
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia